Migraine accounts for roughly 60% of all neurological disability and, thanks to its clinical nature and high prevalence, more disability than depression, diabetes, asthma and osteoarthritis.
Read MoreWe find ourselves in the midst of a second revolution, this time involving migraine prevention rather than the acute treatment of migraine.
Read MoreErenumab (Aimovig) is the first designer drug for migraine since Glaxo’s injectable Imitrex was released almost three decades ago.
Read MoreSometimes, despite your best efforts, a migraine attack just will not respond to the therapies you self-administer. At such times the only alternative to suffering at home may be a visit to a healthcare facility for help.
Read MoreHeadaches are a way of life for me, and I’ve learned to live with them. I’ve been on every migraine medication there is, but nothing has worked. The only relief I get is from Lortab. I don’t like the way it makes me feel, but at least I can function. My doctor will only prescribe 30 Lortab pills a month.
Read MoreOn any given day, Dr. Krymchantowski can be found caring for headache patients in his clinic in Ipanema or piloting a helicopter on a mission to rescue wounded police officers in his native city, Rio de Janeiro.
Read MoreLigia was born in Quetzaltenango, Guatemala and has lived in the United States since 1994. She has painted her entire life. She holds a degree in graphic design and has mastered a variety of art forms, including oil, watercolor, acrylic and collage.
Read MoreMany healthcare providers and those afflicted with the disorder often refer to cluster as “the King of Headaches”. Its more somber and unfortunately well-deserved nickname is “The Suicide Headache”.
Read MoreLearn how doctors are treating chronic migraine with botox and get the facts about migraine and menopause.
Read MoreMigraineur magazine a unique resource for those who seek “to live well despite migraine”. Written by medical professionals with extensive backgrounds in clinical work, research and education involving migraine, our informational content goes well beyond what typically is offered via headache websites and other health magazines.
Read MoreOn May 17 came public announcement of the Federal Drug Administration’s approval of Aimovig (erenumab). Amongst the CGRP antagonists, a new class of migraine medications designed specifically to treat migraine, Aimovig is the first to become available for general clinical use.
Read MoreMigraineur magazine is intended to both educate and entertain the many millions of people who suffer from migraine.
Blending information with enlivening entertainment, Migraineur is a unique resource for those who seek "to live well despite migraine". Written by medical professionals with extensive backgrounds in clinical work, research and education involving migraine, Migraineur's informational content goes far beyond what typically is offered via headache websites and other health magazines.
In doing so, however, the writers make a particular effort to ensure their articles offer an abundance of pragmatic advice relevant to the readers' needs, are enhanced by visually appealing graphics and are leavened with a healthy dose of humor. This is neither Readers Digest for migraine sufferers nor a dreary recitation of medical facts and statistics.
Instead, Migraineur is intended for a readership devoted to living healthy, productive and interesting lives. It is, put simply, a guide for living well and fully despite migraine.
For information regarding submissions advertising, letters-to-the-editor or other issues, contact the magazine's editorial office at: edoffice@migraineurmagazine.com
"Migraineur" has thousands of electronic subscribers throughout the U.S. and internationally. Become a subscriber, and you automatically will receive electronic notifications and the relevant links as soon as new issues are published or when blogs and special announcements are posted to the website to alert readers to new developments that occur between the publication of the quarterly issues. Subscribing to the magazine is simple and, better yet, free. Click below, provide your name, email address, and ZIP Code, and - voilà! - you are a subscriber.
Migraineur Wiki Page
View PDF
Spring 2024 Issue
Read online
Winter 2024 Issue
Read online
Fall 2023 Issue
Read online
Summer 2023 Issue
Read Online
Spring 2023 Issue
Read Online
Winter 2023 Issue
Read Online
Fall 2022 Issue
Read Online
Summer 2022 Issue
Read Online
Spring 2022 Issue
Read Online
Winter 2021-22 Issue
Read Online
Fall 2021 Issue
Read Online
Summer 2021 Issue
Read Online
Spring 2021 Issue
Read Online
Spring 2020 Issue
Read Online
Spring 2019 Issue
Read Online
Summer 2018 Issue
Read Online
About Contact Us Subscribe RSS Sitemap
Migraineur magazine is intended to both educate and entertain the many millions of people who suffer from migraine.
©2021 Celerity Press
🍀 Website design by Clover Collective
